oncolytic measles virus encoding thyroidal sodium iodide symporter Report issue

Biological Experimental
AACT

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

Alternative names

oncolytic measles virus encoding thyroidal sodium iodide symporter

Organizations (2)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (11)


 

Breast Neoplasms (Phase 1)

Fallopian Tube Neoplasms (Phase 2)

Hamartoma (Phase 2)

Mesothelioma (Phase 1)

Multiple Myeloma (Phase 2)

Neoplasm Metastasis (Phase 1)

Nerve Sheath Neoplasms (Phase 1)

Neurofibromatosis 1 (Phase 1)

Ovarian Diseases (Phase 2)

Ovarian Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue